NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1050230186

Registered date:22/02/2024

A cross-sectional web survey study to clarify reality of EGPA related symptoms in patients with eosinophilic granulomatosis with polyangiitis (KUNPU study)

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedEosinophilic granulomatosis with polyangiitis
Date of first enrollment20/02/2024
Target sample size200
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeProportion of patients with EGPA with each EGPA related symptom by severity
Secondary Outcome1. Proportion of patients with EGPA by total number of EGPA related symptoms according to the 13 items 2. Proportion of patients with EGPA by most painful symptom 3. Proportion of patients with EGPA with each EGPA related symptom by severity in EGPA relapse Proportion of patients with EGPA by total number of EGPA related symptoms according to the 13 items in EGPA relapse Proportion of most painful symptom among symptoms of patients with EGPA in EGPA relapse 4. Proportion of patients with EGPA with EGPA related daily trouble

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
Gender
Include criteria1. Informed consent on the website 2. Females and males aged >=18 years at time of enrollment 3. History of physician-diagnosed EGPA more than 1 year ago and those who have been receiving treatment before enrollment
Exclude criteriaNo exclusion criteria is set for this web survey.

Related Information

Contact

Public contact
Name Hitomi Uchimura
Address Grand Front Osaka Tower B 3-1, Ofuka-cho, Kita-ku, Osaka-city, Osaka 530-0011, JAPAN Osaka Japan 530-0011
Telephone +81-6-4802-3600
E-mail hitomi.uchimura@astrazeneca.com
Affiliation AstraZeneca K.K.
Scientific contact
Name Michio Tanaka
Address Grand Front Osaka Tower B 3-1, Ofuka-cho, Kita-ku, Osaka-city, Osaka 530-0011, JAPAN Osaka Japan 530-0011
Telephone +81-6-4802-3600
E-mail michio.tanaka@astrazeneca.com
Affiliation AstraZeneca K.K.